Khary K Rigg
Overview
Explore the profile of Khary K Rigg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
527
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Rigg K, Proctor S, Kusiak E, Barber S, Asous L, Bartholomew T
J Behav Health Serv Res
. 2025 Feb;
PMID: 39934568
No abstract available.
3.
Rigg K, Kusiak E, Proctor S, Barber S, Asous L, Bartholomew T
Psychol Serv
. 2024 Aug;
PMID: 39207368
Interventions for substance use disorders (SUDs) are typically delivered face-to-face or remotely via telehealth. In recent years, there has been a rapid rise in the number of SUD services delivered...
4.
Tran J, Rigg K, Galea J, Kosyluk K
J Homosex
. 2024 Jun;
:1-18.
PMID: 38923913
Introduction: Sexual and gender minority (SGM) individuals living with mental illness often experience stigma associated with marginalized identities of sexual orientation, gender identity, and mental illness (MI). Sharing stories of...
5.
Rigg K
Subst Use Misuse
. 2024 Mar;
59(8):1271-1274.
PMID: 38501692
Recent data show that African Americans (AAs) experienced a greater increase in overdose deaths involving prescription opioids relative to other racial/ethnic groups. One possible mechanism through which elevated risk for...
6.
Rigg K
Drug Alcohol Depend
. 2024 Mar;
257:111260.
PMID: 38492256
Background: Extended-release naltrexone (XR-NTX; Vivitrol®) is a long-acting injectable form of naltrexone, which is a medication used to treat opioid use disorder (OUD). In 2010, XR-NTX received Food and Drug...
7.
Rigg K, Weiner M, Kusiak E
J Behav Health Serv Res
. 2024 Mar;
PMID: 38468073
In the United States, opioid-related deaths involving polydrug use are now more prevalent than those involving only opioids. What often goes unnoticed is that deaths involving more than one substance...
8.
Rigg K, Kusiak E, Rigg L
Subst Use Addctn J
. 2024 Jan;
45(2):240-249.
PMID: 38258821
Background: A wide range of opioid misuse motives have been documented in the literature, including to relieve physical pain, feel good/get high, relax, manage feelings/emotions, sleep, and moderate the effects...
9.
Rigg K, Kusiak E
Harm Reduct J
. 2023 Dec;
20(1):179.
PMID: 38110965
Background: Fentanyl is a powerful synthetic opioid that is 50 times more powerful than heroin and has become ubiquitous in the illicit drug supply in the USA. Studies show that...
10.
Rigg K, Proctor S, Kusiak E, Barber S, Asous L, Bartholomew T
J Behav Health Serv Res
. 2023 Dec;
51(2):151-163.
PMID: 38097913
Families Facing the Future (FFF) is an intervention designed specifically for families with a parent in methadone treatment. FFF is unique because it addresses prevention for children and recovery for...